Bayer, DE000BAY0017

Aspirin Complex by Bayer AG - granules aimed at cold relief

Published on 07/21/2026 at 21:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aspirin Complex granules from Bayer AG combine acetylsalicylic acid with pseudoephedrine to tackle pain and nasal congestion in one sachet. Anyone holding Bayer AG stock (ISIN DE000BAY0017) should know this product.

Börsen-Editorial: Handelsraum mit großen LED-Bildschirmen, DAX-Candlestick-Chart in Grün, im Vordergrund ein Pillenflakon mit weißen Tabletten neben einer Tastatur
Trading-Floor mit DAX-Kursanzeige auf Großbildschirm, Tablettenflakon im Vordergrund, Illustration mit AI erstellt.

Aspirin Complex granules sit in a small white sachet that crackles when you tear it open, the fine powder sliding into a glass of water before turning slightly cloudy. This cold and flu remedy from Bayer AG targets pain and blocked noses in one go.

What Aspirin Complex actually is

Aspirin Complex is a medicinal product in granule form that is dissolved in water and swallowed, designed specifically to treat symptoms of colds with pain and nasal congestion. It combines acetylsalicylic acid, better known as aspirin, with pseudoephedrine hydrochloride as a decongestant.

Each sachet typically contains 500 mg acetylsalicylic acid and 30 mg pseudoephedrine hydrochloride, a combination used to relieve headache, sore throat, fever and stuffy nose in adults and adolescents over 16 years. The product is classified as an over-the-counter pharmacy medicine in several European markets, including Germany.

Dig deeper & contextualize

Bayer AG and its cold remedies portfolio

Learn how Aspirin Complex fits into Bayer AG's broader consumer health strategy and revenue streams.

How the granules are used

In a typical German pharmacy setting, pharmacists advise adult customers to dissolve one or two sachets of Aspirin Complex granules in a glass of water and drink the solution. According to Bayer's patient information leaflet, the maximum daily dose is six sachets, and treatment is restricted to short-term use.

The granules are flavored slightly, but the primary sensory impression is the medicinal, mildly bitter taste of acetylsalicylic acid once dissolved. Users are told to take the product with food or after meals if they have a sensitive stomach, because aspirin can irritate the gastric lining.

Safety profile and warnings

Bayer highlights that Aspirin Complex should not be taken by children under 16 due to the risk of Reye's syndrome associated with acetylsalicylic acid in viral illnesses. Patients with severe hypertension, coronary heart disease or taking monoamine oxidase inhibitors are warned against the pseudoephedrine component.

The package insert lists contraindications such as hypersensitivity to aspirin, history of asthma triggered by salicylates, active gastric or duodenal ulcers, or severe kidney or liver impairment. Common side effects include gastrointestinal discomfort, nervousness or insomnia from pseudoephedrine, and in rare cases allergic reactions.

Position in Bayer's consumer health portfolio

In the consumer health division, Aspirin Complex is part of Bayer's global Aspirin brand family, which includes standard aspirin tablets, cardio formulations and other cold remedies. CEO Bill Anderson has repeatedly underlined consumer health brands as a stable cash generator alongside the pharmaceuticals and crop science businesses.

Within cold and flu products, Bayer markets different formulations and brands, but Aspirin Complex targets adults looking for fast pain relief plus nasal decongestion in one product. Its pharmacy-only status in many countries positions it slightly above simple over-the-counter analgesics in perceived strength and margin.

Market presence and availability

In Germany, Aspirin Complex is sold predominantly through pharmacies and online pharmacy platforms, often in packs of 10 or 20 sachets. Pricing varies by retailer, but online listings for 10-sachet packs typically range around 8 to 12 euros, depending on discounts and promotions.

Bayer also offers Aspirin Complex in other European markets, including Austria and Switzerland, with similar compositions but localized packaging and language. In some countries, slightly different dosage recommendations or regulatory classifications apply, reflecting national health authority decisions.

Regulatory status and labeling

As a medicine, Aspirin Complex carries an authorization number from national medicines agencies, and its packaging prominently displays active ingredients, dosage and warnings. The granules are usually packed in individual sachets within a cardboard box, both bearing Bayer's cross logo.

The summary of product characteristics indicates that pseudoephedrine's vasoconstrictive effect in nasal mucosa reduces swelling, while acetylsalicylic acid inhibits cyclooxygenase, lowering prostaglandin production and thereby pain and fever. This dual-action mechanism is central to the product's positioning against common cold symptoms.

Competitive environment

Aspirin Complex competes with multi-symptom cold remedies from other manufacturers, such as paracetamol-plus-decongestant combinations or ibuprofen-based solutions. Due to the aspirin component, Bayer's product appeals to consumers familiar with the Aspirin brand and willing to accept its known side-effect profile.

Pharmacists often compare Aspirin Complex with alternatives on the basis of active ingredients, advising patients who have stomach issues or anticoagulant therapy to consider non-aspirin products instead. This counselling role influences product choice at the pharmacy counter and impacts Bayer's volumes.

Role of Bayer management

Bill Anderson, who took over as CEO of Bayer AG in 2023, has been vocal about focusing the group's portfolio and improving profitability. In analyst briefings, he pointed to consumer health, including brands like Aspirin, as providing resilient cash flow that supports restructuring and investment in pharmaceuticals and crop science.

While individual over-the-counter products like Aspirin Complex are small compared with blockbuster prescription drugs, their cumulative contribution and brand recognition matter for Bayer's consumer health strategy. The product embodies a classic, trusted ingredient with an added decongestant twist for modern cold therapy.

Stock context

From a market perspective, Aspirin Complex is one of many recurring revenue streams in Bayer's consumer health division, helping to balance more volatile earnings in pharmaceuticals and crop science. On Xetra, Bayer AG stock trades in euros and reflects investor expectations on the success of these brands as part of the overall portfolio.

Key data on Aspirin Complex

  • Product: Aspirin Complex granules
  • Manufacturer: Bayer AG
  • Category: Novelty/Launch cold and flu remedy
  • Market launch: Gradual launches in European markets since the late 1990s
  • MSRP / Price: Approx. 8–12 EUR for a 10-sachet pack in Germany
  • Availability: Pharmacy and online pharmacy channels in Germany and selected European markets
  • Target group: Adults and adolescents over 16 with cold symptoms including pain and nasal congestion
  • Highlight / USP: Combination of acetylsalicylic acid and pseudoephedrine in dissolvable granules for simultaneous pain relief and nasal decongestion

Social media impressions

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE000BAY0017 | BAYER | boerse | 69827116 |